Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety of Pandemic Influenza A (H1N1)Vaccine”

33 trials

Showing 20 of 33 results

Large-scale testing (Phase 3)Study completedNCT01053143
What this trial is testing

Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India

Who this might be right for
InfluenzaPandemic InfluenzaInfluenza A Virus, H1N1 Subtype
Sanofi Pasteur, a Sanofi Company 100
Large-scale testing (Phase 3)Study completedNCT00971100
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 752
Not applicableStudy completedNCT01037855
What this trial is testing

Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

Who this might be right for
Novel Influenza A (H1N1)A New Flu Virus of Swine Origin
Novartis Vaccines 4,028
Large-scale testing (Phase 3)Study completedNCT00970177
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 812
Testing effectiveness (Phase 2)Study completedNCT00992212
What this trial is testing

Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

Who this might be right for
Pandemic Influenza Disease
Novartis Vaccines 418
Large-scale testing (Phase 3)Study completedNCT00971425
What this trial is testing

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

Who this might be right for
Influenza
GlaxoSmithKline 145
Not applicableStudy completedNCT01101074
What this trial is testing

Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Who this might be right for
Influenza A (H1N1)
Novartis Vaccines 135,469
Testing effectiveness (Phase 2)WithdrawnNCT00989274
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Who this might be right for
Influenza
Instituto Nacional de Salud Publica, Mexico
Testing effectiveness (Phase 2)Study completedNCT00976469
What this trial is testing

A/H1N1 Immunogenicity and Safety in Infants, Children and Adolescents

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 400
Testing effectiveness (Phase 2)Study completedNCT00959465
What this trial is testing

A/H1N1 Immunogenicity and Safety in Adults

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 408
Testing effectiveness (Phase 2)Study completedNCT00953524
What this trial is testing

Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 849
Testing effectiveness (Phase 2)Study completedNCT00952276
What this trial is testing

Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi 548
Testing effectiveness (Phase 2)Study completedNCT01666262
What this trial is testing

Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais

Who this might be right for
Healthy
Mahidol University 363
Not applicableStudy completedNCT01040741
What this trial is testing

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Who this might be right for
Pandemic Influenza A (H1N1)A New Flu Virus of Swine Origin
Novartis Vaccines 7,284
Not applicableStudy completedNCT00950456
What this trial is testing

Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine

Who this might be right for
InfluenzaPandemic Influenza
Alachua Government Services, Inc. 3,216
Not applicableStudy completedNCT01037829
What this trial is testing

Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study

Who this might be right for
Influenza
Novartis Vaccines 4,529
Early research (Phase 1)Study completedNCT01111968
What this trial is testing

Evaluation of Pandemic Influenza A (H1N1)Candidate Vaccines

Who this might be right for
Influenza
Butantan Institute 266
Testing effectiveness (Phase 2)Study completedNCT01161160
What this trial is testing

Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

Who this might be right for
Influenza
GlaxoSmithKline 209
Large-scale testing (Phase 3)Study completedNCT00971542
What this trial is testing

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age

Who this might be right for
Pandemic Influenza
Novartis Vaccines 778
Testing effectiveness (Phase 2)Study completedNCT00954798
What this trial is testing

Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly

Who this might be right for
InfluenzaSwine-origin A/H1N1 Influenza
Sanofi Pasteur, a Sanofi Company 450
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation